The inter-consortium thematic group "Non-Communicable Diseases" (NoCoD) of the Franco-Indian Campus for Life Sciences and Health (CFI-SVS) aims to address the growing health challenges associated with chronic diseases such as cardiovascular diseases, diabetes, neurological diseases, cancers, and metabolic disorders. This group leverages the distinct and complementary expertise of the following consortia: BIOSANTEXC, ILIADE, SHIELD, and Integrated Health.

coordinated by École Normale Supérieure (ENS) Lyon and the Indian Institute of Science Education and Research (IISER) Pune, provides fundamental scientific contributions, particularly in the fields of functional genomics, neuroscience, and biochemistry applied to chronic diseases. This consortium is notably active in establishing biomarker studies and relevant experimental models to understand and treat non- communicable diseases, enhancing researcher exchanges and Franco-Indian co-supervised doctoral training.

ILIADE, coordinated by the University of La Réunion and the Vellore Institute of Technology (VIT), contributes with a unique approach focused on biotechnology applied to medicinal plants and artificial intelligence applied to biomedical data. In the context of chronic diseases, ILIADE focuses on identifying and validating natural molecules with therapeutic potential against diabetes and metabolic disorders, using computational approaches and experimental trials. The consortium also emphasizes a strong educational dimension through specialized master's modules.

Integrated Health, led by Sorbonne University and the Indian Institute of Technology (IIT) Delhi, offers integrated and translational expertise, combining fundamental sciences, biomedical engineering, and humanities applied to health. The consortium particularly targets neurodegenerative diseases, cognitive disorders, as well as cardiovascular and metabolic diseases, with a strong clinical and hospital dimension. Integrated Health coordinates multicentric studies, pilot clinical trials, and training programs in clinical medicine and public health.

SHIELD, led by the University Nice Côte d’Azur (UniCA), in partnership with the Indraprastha Institute of Information Technology Delhi (IIITD), Ashoka University, and the Indian Institute of Science (IISc) Bangalore, provides advanced expertise in computational sciences, bioinformatics, and artificial intelligence applied to non communicable diseases. SHIELD specifically works on developing innovative tools for risk prediction, early diagnosis, and personalized treatment of cancers and cardiovascular disorders. The consortium is notably involved in structuring a dual-degree program in health bioinformatics.